Psyence Biomedical Ltd.
13F holders, Q3 2025 (September 30)6holders +1
3new positions
2sold out
$4.36avg. 13F price*
At the end of Q3 2025, 6 institutions reported holding Psyence Biomedical Ltd. in their 13F filings, up 1 from Q2 2025. 3 opened new positions and 2 sold out. The largest holders were Parallel Advisors, LLC ($687K), Virtu Financial LLC ($33K) and AdvisorShares Investments LLC ($17K).
- Company
- Psyence Biomedical Ltd.
- CUSIP
- 74449F308
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $734K |
| Exits | 2 | $119K |
All 13F filers, Q2 2025 → Q3 2025: 167,005 shares bought and 22,284 shares sold, net +144,721 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Parallel Advisors, LLC | 0.01% | New | 151,250 | $687K |
| Virtu Financial LLC | 0.00% | New | 10,325 | $33K |
| AdvisorShares Investments LLC | 0.00% | Add +20.9% | 5,378 | $17K |
| Osaic Holdings, Inc. | 0.00% | New | 4,500 | $14K |
| Bank of America Corp. | 0.00% | No change | 3,340 | $11K |
| Stonehage Fleming Financial Services Holdings Ltd | 0.00% | No change | 561 | $2K |
"% of holder's portfolio" is PSYENCE BIOMEDICAL LTD's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.